These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 4722544)
21. Phentolamine inhibition of human growth hormone secretion induced by L-DOPA. Cammani F; Massara F Horm Metab Res; 1972 Mar; 4(2):128. PubMed ID: 4554974 [No Abstract] [Full Text] [Related]
22. The Albright syndrome associated with acromegaly: report of a case and review of the literature. Lipson A; Hsu TH Johns Hopkins Med J; 1981 Jul; 149(1):10-4. PubMed ID: 7019531 [TBL] [Abstract][Full Text] [Related]
23. Changes in plasma growth hormone levels after surgical treatment of acromegaly. Jacobs HS; Greenwood FC; Nabarro JD Proc R Soc Med; 1970 Mar; 63(3):223-4. PubMed ID: 5445553 [No Abstract] [Full Text] [Related]
24. The response of serum growth hormone to central and peripheral dopaminergic stimuli in normal subjects and in acromegalic patients. Oma H; Kato K; Takahashi H; Ibayashi H Fukuoka Igaku Zasshi; 1982 Mar; 73(3):179-88. PubMed ID: 7106688 [No Abstract] [Full Text] [Related]
25. Use of the oral glucose tolerance test to define remission in acromegaly. Vierhapper H; Heinze G; Gessl A; Exner M; Bieglmayr C Metabolism; 2003 Feb; 52(2):181-5. PubMed ID: 12601629 [TBL] [Abstract][Full Text] [Related]
26. L-dopa therapy in parkinsonism: mechanism of action. Sandler M Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239 [No Abstract] [Full Text] [Related]
27. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198 [TBL] [Abstract][Full Text] [Related]
28. Influence of L-dopa on the EEG and EMG in Parkinson patients. Visser SL; Postma JU Psychiatr Neurol Neurochir; 1971; 74(4):315-21. PubMed ID: 5146237 [No Abstract] [Full Text] [Related]
29. Hormonal diagnosis of GH hypersecretory states. Grottoli S; Gasco V; Ragazzoni F; Ghigo E J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657 [TBL] [Abstract][Full Text] [Related]
30. [L-dopa and somatotropin secretion in humans]. Giordano G; Marugo M; Minuto F; Barreca T; Foppiani E Folia Endocrinol; 1973 Dec; 26(6):523-37. PubMed ID: 4801262 [No Abstract] [Full Text] [Related]
32. [Peripheral thyroid function and TRH-TSH test in patients with acromegaly]. Heberling HJ; Heilmann W; Ulrich FE; Schneyer U Z Gesamte Inn Med; 1981 Apr; 36(8):306-8. PubMed ID: 6792802 [TBL] [Abstract][Full Text] [Related]
33. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Minuto F; Resmini E; Boschetti M; Arvigo M; Sormani MP; Giusti M; Ferone D; Barreca A Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656 [TBL] [Abstract][Full Text] [Related]
34. Effects of somatostatin in parkinsonism, growth hormone, and dopa metabolism. Papavasiliou PS; Cotzias GC; Rubin JI; Rosal VL; Wang YY Trans Am Neurol Assoc; 1977; 102():90-3. PubMed ID: 616124 [No Abstract] [Full Text] [Related]
35. Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration. Podolsky S; Leopold NA J Clin Endocrinol Metab; 1974 Jul; 39(1):36-9. PubMed ID: 4276011 [No Abstract] [Full Text] [Related]